Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04460430
Brief Title: Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer (NEREA)

First Submitted : June 29, 2020
First Submitted that Met QC Criteria : July 1, 2020
First Posted : July 7, 2020

Last Update Submitted that Met QC Criteria : July 23, 2021
Last Update Posted : July 26, 2021